Extended Anti-CD20 Dosing Shows Promise for Multiple Sclerosis Safety
A collaborative expert review highlights that extending anti-CD20 infusion intervals in stable multiple sclerosis patients may preserve neuroinflammatory disease control ...
A collaborative expert review highlights that extending anti-CD20 infusion intervals in stable multiple sclerosis patients may preserve neuroinflammatory disease control ...
A retrospective cohort study found ocrelizumab induced predictable, class-specific immunoglobulin declines in multiple sclerosis patients without increasing short-to-mid-term clinically relevant ...
A five-year multicenter registry study revealed that nusinersen therapy sustained significant motor score improvements in pediatric spinal muscular atrophy patients ...
A retrospective study of over 1,000 multiple sclerosis patients shows that while relapse rates and relapse-associated disability have declined over ...
A pharmacovigilance analysis of over one million adverse event reports found disproportionate reporting signals for progressive multifocal leukoencephalopathy with natalizumab ...
A case report details how sexual dysfunction served as the earliest prodromal sign of autonomic neuropathy in a patient with ...
In a brief research report, investigators found that a low CXCL13 index predicts the safety of monitoring patients with an ...
A study comparing MRL and C57BL/6J mice reveals that enhanced antioxidant and detoxification programs in MRL mice are associated with ...
A single-arm clinical trial found that nine days of robot-assisted gait training with the Hybrid Assistive Limb was associated with ...
A new chemically modified antisense oligonucleotide, LF-ASO-001, shows promise as a disease-modifying therapy for osteoarthritis by destabilizing the AGO2-miR-204-5p complex ...
A new review details how engineered alpha-synuclein mouse models with defined biochemical defects are transforming Parkinson's disease therapy development.
A new review argues that acetylcholinesterase acts beyond breaking down acetylcholine, accelerating amyloid-beta aggregation and tau pathology while remaining a ...
A study of 37 SMA patients in Milan finds serum myostatin correlates with motor function and disease severity, while Smad3 ...
A UK modified Delphi consensus of 19 experts has produced 22 statements recommending that patients with spinal muscular atrophy on ...
A Latvian retrospective cohort of 56 patients found that progressive late-onset multiple sclerosis was associated with more motor and sphincter ...
A new narrative review finds that GLP-1 receptor agonists like semaglutide and tirzepatide are safe and effective for weight loss ...
A new qualitative study from West China Hospital reveals how family caregivers of Alzheimer's patients in China experience lecanemab treatment, ...
A new analysis of more than 4,000 users of the German multiple sclerosis app Brisa reveals shifting treatment patterns, stable ...
A new review in the Journal of Neurology charts the rapid evolution of treatments for myotonic disorders, from established sodium ...
A new time-to-event analysis of early Parkinson's disease trials shows that large, clinically meaningful worsening thresholds can be detected within ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.